Qardio, a leading innovator in healthcare technology, has unveiled its groundbreaking Livestream solution suite, which includes continuous ECG, Blood Pressure, Pulse Oximetry (SPO2), Body Temperature, Weight, and Body Position monitoring
June 21, 2023
Qardio Introduces Revolutionary Livestream ECG Monitoring and Advances Healthcare
June 21, 2023 — Qardio, a leading innovator in healthcare technology, has unveiled its groundbreaking Livestream…
Read More
Qardio, a leading innovator in healthcare technology, has unveiled its groundbreaking Livestream solution suite, which includes continuous ECG, Blood Pressure, Pulse Oximetry (SPO2), Body Temperature, Weight, and Body Position monitoring
June 21, 2023
Philips and BIOTRONIK Expand Care for Out-of-hospital Cardiology Labs with New Strategic Alliance
June 21, 2023 — Royal Philips, a global leader in health technology, announced it has teamed up with BIOTRONIK (Lake…
Read More
June 21, 2023
American Heart Association Releases Scientific Statement on Reducing Disparities in Peripheral Artery Disease with Routine Tests
June 21, 2023 — A new science report issued by the American Heart Association (AHA) emphasizes the importance of…
Read More
The US Food and Drug Administration has approved the use of iTFlow in blood flow analysis. The FDA approval is significant as it recognizes the safety and effectiveness of iTFlow in analyzing blood flow through 4D Flow MRI data, with the potential to enhance diagnostic accuracy for patients with cardiovascular diseases and heart conditions.
June 20, 2023
FDA Approves Innovative 4D Flow MRI Blood Flow Analysis Software from Cardio Flow Design Inc.
June 20, 2023 — The US Food and Drug Administration has approved the use of iTFlow in blood flow analysis. The FDA…
Read More
LODOCO (colchicine, 0.5 mg tablet) Reduces Cardiac Event Risk in Adult Patients with Established Atherosclerotic Cardiovascular Disease (ASCVD) by an Additional 31% on Top of Standard of Care
June 20, 2023
U.S. FDA Approves First Anti-Inflammatory Drug for Cardiovascular Disease
June 20, 2023 — AGEPHA Pharma USA, LLC, announced that, following a Priority Review, the U.S. Food and Drug…
Read More
June 20, 2023
Advanced Medical Algorithm-based Chatbot, Pāṇini, Revolutionizes Clinical Outcomes
June 20, 2023 — Pāṇini, an AI-powered chatbot developed by doctors for doctors, has officially launched, aiming to…
Read More
Patients who had heart attacks during the first COVID-19 lockdown in the UK and Spain are predicted to live 1.5 and 2 years less, respectively, than their pre-COVID counterparts.
June 19, 2023
One Month of COVID-19 Lockdown Cost Heart Attack Patients Up to Two Years of Life
June 19, 2023 — Patients who had heart attacks during the first COVID-19 lockdown in the UK and Spain are predicted to…
Read More
Luscii Virtual Heart Clinic aims to provide cardiologists with a comprehensive, easy-to-use app to offer remote cardiac patient monitoring to their patients. The app prompts patients to take measurements of vital signs which are automatically analysed to detect abnormalities.
June 19, 2023
AliveCor Collaborates with European Market Leader in Remote Patient Monitoring Luscii to Offer World's First 'Virtual Heart Clinic in a Box'
June 19, 2023 — AliveCor, a global leader in personal electrocardiogram (ECG) technology, has announced a…
Read More
Endologix LLC, a privately held, global medical device company dedicated to providing disruptive therapies for the interventional treatment of vascular disease, announced that the U.S. Food and Drug Administration (FDA) has granted approval for the DETOUR System to treat patients with complex peripheral arterial disease (PAD).
June 16, 2023
Endologix Announces 24-Month Results of DETOUR- 2 Study at 2023 Vascular Annual Meeting
June 16, 2023 — Endologix LLC, a privately held, global medical device company, dedicated to providing disruptive…
Read More
Out-of-hospital cardiac arrests (OCHA) cause significant mortality and morbidity, and the study is one the largest trials ever conducted on cardiac arrest patients admitted to intensive care units (ICU).
June 16, 2023
New Data from Global TAME Study Supports Current Management of CO2 Levels in Cardiac Arrest Patients
June 16, 2023 — A promising emerging treatment (hypercapnia) for comatose adult cardiac arrest patients has been found…
Read More
June 16, 2023
Esperion Presents Results from New Analysis on Cardiovascular Benefits with Bempedoic Acid Treatment at ENDO 2023
June 16, 2023 — Esperion presented results from an analysis comparing the cardiovascular risk reduction benefits of …
Read More
Dr. Jonathan Weinsaft, an esteemed physician-scientist who focuses on clinical research and cardiovascular imaging, has been appointed chief of the Greenberg Division of Cardiology at Weill Cornell Medicine and NewYork-Presbyterian/Weill Cornell Medical Center, effective July 1.
June 15, 2023
Dr. Jonathan Weinsaft Named Chief of the Greenberg Division of Cardiology at Weill Cornell Medicine and NewYork-Presbyterian/Weill Cornell Medical Center
June 15, 2023 — Dr. Jonathan Weinsaft, an esteemed physician-scientist who focuses on clinical research and …
Read More
Kandu Health is working to fulfill an urgent need in healthcare by supporting stroke patients beyond the hospital through a team of clinically licensed navigators, community support groups, and an easy-to-use app.
June 15, 2023
Kandu Health Achieves Successful Enrollment of the First 50 Stroke Survivors in its Stroke Recovery Program, Appoints New Leadership
June 15, 2023 — Imperative Care, Inc., a medical technology company elevating care for people affected by stroke and…
Read More
Endologix LLC, a privately held, global medical device company dedicated to providing disruptive therapies for the interventional treatment of vascular disease, announced that the U.S. Food and Drug Administration (FDA) has granted approval for the DETOUR System to treat patients with complex peripheral arterial disease (PAD).
June 15, 2023
Endologix Receives FDA Approval of the DETOUR System to Treat Long Complex Superficial Femoropopliteal Lesions in Patients with PAD
June 15, 2023 — Endologix LLC, a privately held, global medical device company dedicated to providing disruptive…
Read More
A University of Waterloo engineer’s MRI invention reveals better than many existing imaging technologies how COVID-19 can change the human brain.
June 14, 2023
New Imaging Technique Captures COVID-19’s Impact on the Brain
June 14, 2023 — A University of Waterloo engineer’s MRI invention reveals better than many existing imaging…
Read More
NIH-supported study could lead to less restrictions for those with hypertrophic cardiomyopathy
June 14, 2023
Vigorous Exercise Not Tied to Increased Risk of Adverse Events in Rare Heart Condition
June 14, 2023 — Vigorous exercise does not appear to increase the risk of death or life-threatening arrhythmia for…
Read More
The OCEANIC-AF (atrial fibrillation) study with asundexian is part of the Phase III OCEANIC clinical trial program enrolling more than 27,000 patients in over 40 countries
June 14, 2023
Bayer Receives U.S. FDA Fast Track Designation for asundexian Atrial Fibrillation Program
June 14, 2023 — Bayer announced that the U.S. Food and Drug Administration (FDA) has granted Fast Track Designation for…
Read More
Novel polymeric valve aims to reduce re-operations and re-interventions
June 13, 2023
PECA Labs Achieves Successful First-In-Human Implant of the MASA Valve Pediatric Pulmonary Valved Conduit in U.S. Clinical Trial
June 13, 2023 — PECA Labs, a medical device company reimagining vascular grafts and valves with durable polymeric…
Read More
The Gore VBX FORWARD Clinical Study aims to compare the VBX Stent Graft primary patency to bare metal stenting to evaluate superiority in treating complex iliac occlusive disease
June 13, 2023
Gore Initiates Study to Compare the Gore Viabahn VBX Balloon Expandable Endoprosthesis to Bare Metal Stents
June 13, 2023 — W. L. Gore & Associates (Gore) announced the initiation of the Gore VBX FORWARD Clinical Study (…
Read More
In combination with BIOTRONIK Home Monitoring the DX ICD system is an effective and convenient way to detect AHRE and monitor atrial fibrillation events and burden
June 13, 2023
REACT DX Registry Highlights Relevance of Atrial High-Rate Episode Remote Monitoring in ICD Patients
June 13, 2023 — A recent study highlights that implantable cardioverter-defibrillator (ICD) patients with new-onset…
Read More
© Copyright Wainscot Media. All Rights Reserved.
Subscribe Now